Cipla share price was trading firm on Friday with 2.4 percent gains over yesterday's close. The stock touched intraday high of Rs 1,527.95 by the time of publication of this report.
Geojit Financial Services has reaffirmed a BUY rating on Aurobindo Pharma Limited with a target price of Rs 1,540, implying a potential upside of 25% from the current market price of Rs 1,229.
Laurus Labs, a major player in the pharmaceutical and biotechnology space, has been gaining traction among investors due to its strong fundamentals and sectoral potential.